Crossmark Global Holdings, Inc. Novartis Ag Transaction History

Crossmark Global Holdings, Inc.

$5.61 Billion
Q3 2024

A detailed history of Crossmark Global Holdings, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 35,617 shares of NVS stock, worth $3.46 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

35,617

Previous 27,793 28.15%

Holding current value

$3.46 Million

Previous $2.96 Million 38.43%

% of portfolio

0.07%

Previous 0.06%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$106.13 - $120.89 $830,361 - $945,843	7,824 Added 28.15%	35,617 $4.1 Million
Q2 2024 Jul 29, 2024	BUY	$92.57 - $107.37 $32,306 - $37,472	349 Added 1.27%	27,793 $2.96 Million
Q1 2024 May 13, 2024	SELL	$95.27 - $108.47 $36,012 - $41,001	-378 Reduced 1.36%	27,444 $2.66 Million
Q4 2023 Feb 13, 2024	BUY	$92.27 - $101.54 $36,723 - $40,412	398 Added 1.45%	27,822 $2.81 Million
Q3 2023 Nov 08, 2023	SELL	$94.73 - $105.13 $365,752 - $405,906	-3,861 Reduced 12.34%	27,424 $2.7 Million
Q2 2023 Jul 31, 2023	BUY	$92.52 - $104.91 $111,671 - $126,626	1,207 Added 4.01%	31,285 $3.26 Million
Q1 2023 May 12, 2023	BUY	$80.03 - $92.81 $37,293 - $43,249	466 Added 1.57%	30,078 $2.77 Million
Q4 2022 Jan 19, 2023	SELL	$75.55 - $92.52 $8,386 - $10,269	-111 Reduced 0.37%	29,612 $2.69 Million
Q3 2022 Nov 01, 2022	BUY	$74.61 - $87.26 $315,824 - $369,371	4,233 Added 16.61%	29,723 $2.26 Million
Q2 2022 Jul 29, 2022	SELL	$80.52 - $93.75 $99,844 - $116,250	-1,240 Reduced 4.64%	25,490 $2.16 Million
Q1 2022 May 11, 2022	BUY	$80.11 - $90.62 $135,385 - $153,147	1,690 Added 6.75%	26,730 $2.35 Million
Q4 2021 Jan 10, 2022	BUY	$79.7 - $88.13 $2,391 - $2,643	30 Added 0.12%	25,040 $2.19 Million
Q3 2021 Oct 21, 2021	BUY	$81.78 - $95.14 $509,489 - $592,722	6,230 Added 33.17%	25,010 $2.05 Million
Q3 2021 Oct 13, 2021	SELL	$81.78 - $95.14 $2.87 Million - $3.33 Million	-35,050 Reduced 65.11%	18,780 $1.15 Million
Q2 2021 Jul 21, 2021	SELL	$85.24 - $94.15 $1.1 Million - $1.21 Million	-12,850 Reduced 19.27%	53,830 $4.91 Million
Q1 2021 Apr 15, 2021	SELL	$83.5 - $98.47 $1.06 Million - $1.25 Million	-12,706 Reduced 16.01%	66,680 $5.7 Million
Q4 2020 Jan 14, 2021	BUY	$78.07 - $94.43 $47,154 - $57,035	604 Added 0.77%	79,386 $7.5 Million
Q3 2020 Oct 08, 2020	BUY	$82.14 - $91.0 $1.28 Million - $1.42 Million	15,560 Added 24.61%	78,782 $6.85 Million
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $2.51 Million - $2.82 Million	-30,953 Reduced 32.87%	63,222 $5.52 Million
Q1 2020 Apr 28, 2020	SELL	$70.67 - $99.01 $363,667 - $509,505	-5,146 Reduced 5.18%	94,175 $7.76 Million
Q4 2019 Feb 06, 2020	BUY	$84.35 - $95.37 $1.96 Million - $2.21 Million	23,182 Added 30.45%	99,321 $9.41 Million
Q3 2019 Oct 09, 2019	SELL	$85.54 - $94.26 $2.39 Million - $2.64 Million	-27,955 Reduced 26.86%	76,139 $6.62 Million
Q2 2019 Jul 09, 2019	SELL	$75.4 - $92.8 $731,757 - $900,624	-9,705 Reduced 8.53%	104,094 $9.51 Million
Q1 2019 May 02, 2019	BUY	$75.32 - $86.15 $186,793 - $213,652	2,480 Added 2.23%	113,799 $10.9 Million
Q4 2018 Jan 31, 2019	SELL	$73.66 - $82.02 $44,932 - $50,032	-610 Reduced 0.54%	111,319 $9.55 Million
Q3 2018 Nov 08, 2018	BUY	$66.94 - $77.43 $1.62 Million - $1.88 Million	24,246 Added 27.65%	111,929 $9.64 Million
Q2 2018 Jul 31, 2018	SELL	$64.91 - $73.36 $3.68 Million - $4.16 Million	-56,689 Reduced 39.27%	87,683 $6.62 Million
Q1 2018 Apr 16, 2018	BUY	$70.39 - $84.15 $899,443 - $1.08 Million	12,778 Added 9.71%	144,372 $11.7 Million
Q4 2017 Feb 05, 2018	SELL	$72.33 - $77.64 $1.06 Million - $1.14 Million	-14,696 Reduced 10.05%	131,594 $11 Million
Q3 2016 Oct 25, 2017	BUY	N/A	146,290	146,290 $12.6 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account

Crossmark Global Holdings, Inc. Novartis Ag Transaction History